Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-079132
Filing Date
2023-07-07
Accepted
2023-07-07 16:16:30
Documents
1
Period of Report
2023-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320607-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2320607-1_3seq1.xml 3 1601
  Complete submission text file 0001104659-23-079132.txt   3204
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHIBRO ANIMAL HEALTH CORP 300 FRANK W. BURR BOULEVARD, STE 21 TEANECK NJ 07666
Business Address
Weinstein Judith (Reporting) CIK: 0001982496 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 231076974